SpaceX Scrubs Starship Test Flight Plans Friday Attempt as V3 Debut Approaches
Borosil Glass Works Surges Over 200 in One Year Whats Driving the Momentum
White House Highlights Soybean and Rare Earth Deals From TrumpXi Summit China Emphasizes Tariff Cut Possibilities
Dropbox Founder Drew Houston Steps Down as CEO After 19 Years Transitions to Executive Chairman
GameSquare Holdings Receives Amended Schedule 13D Filing
Berkshire Hathaway Revives Airline Bet with 26 Billion Stake in Delta Air Lines
Nucor Q1 2026 Earnings Steelmaker Beats Profit Expectations as Shares Advance
CTAS Q1 2026 Earnings EPS Misses Estimates as Revenue Data Remains Unavailable
Mesabi Trust MSB Q1 2026 Earnings EPS of 021 Highlights Ongoing Iron Ore Headwinds
GTES Q1 2026 Earnings EPS Beat with 47 Surprise Amid Steady Demand
BioHarvest Sciences Q1 2025 Earnings EPS Misses Estimates Stock Gains Amid Operational Progress
American Coastal Insurance Corporation Q1 2026 Earnings EPS Falls Short of Estimates Stock Declines
OXSQG Holds Steady at 2435 as FixedIncome Investors Eye Rate Environment
Infinity Natural Resources INR Holds Steady Near Support Targets Resistance Breakout
Generation Essentials Group TGE Holds Support Eyes Resistance at 111
Flexsteel Industries FLXS Nears Support After Modest Pullback
DTW Inches Higher Amid FixedIncome Stability Debenture Holds Steady at 2116
South Koreas Deputy PM Warns AI Wealth Must Benefit Public Amid Samsung Labor Tensions
Seer Inc Q1 2026 Earnings Narrower Loss Per Share Leads to Modest Stock Gain
EDAP TMS Holds Steady Near Support After Modest Gain
Avanos Medical AVNS Holds Steady Near Key Support Treading Water or Poised for a Move
iQSTEL Inc IQST Falls 331 as Shares Test Key Support Levels
DRTSW Plunges 14 as Selling Pressure Intensifies Key Support Levels in Focus
Nuveen Municipal Credit Income Fund NZF Holds Steady Near Resistance as Income Seekers Eye Yield
Espey Mfg Electronics Corp ESP Edges Higher Amid Consolidation Near Key Resistance
Occidental Petroleum OXY Gains Modestly as Support Holds Above Key Level
Beam Therapeutics BEAM Edges Higher as Investors Weigh Gene Editing Sector Outlook